pharma · Non-Hodgkin Lymphoma · Advanced Solid Tumors · ADCT
ADC Therapeutics
ADC Therapeutics SA
ADC Therapeutics clinical programs — 14 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Lausanne, Vaud, Switzerland, CH
- Founded
- 2011
- Employees
- 272
- Programs
- 30
- Drugs
- 15
- Patents
- 22
ADC Therapeutics projects
14 ClinicalTrials.gov programs sponsored by ADC Therapeutics.
ADC Therapeutics has 14 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ADCT-301
ADC Therapeutics SA
Acute Myeloid Leukemia
1 trial -
ADCT-301
ADC Therapeutics SA
Head and Neck Cancer Squamous Cell Carcinoma
1 trial -
ADCT-402
ADC Therapeutics SA
Acute Lymphoblastic Leukemia
1 trial -
ADCT-402
ADC Therapeutics SA
Non-Hodgkin Lymphoma
1 trial -
ADCT-402-105
ADC Therapeutics SA
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
1 trial -
ADCT-502
ADC Therapeutics SA
Breast Cancer
1 trial -
ADCT-601
ADC Therapeutics SA
Advanced Solid Tumors
2 trials -
ADCT-901
ADC Therapeutics SA
Advanced Solid Tumors
1 trial -
Camidanlumab tesirine
ADC Therapeutics SA
Hodgkin Lymphoma
1 trial -
Carmustine
ADC Therapeutics SA
Recurrent Diffuse Large B-Cell Lymphoma
1 trial -
Loncastuximab Tesirine
ADC Therapeutics SA
B-Cell Non-Hodgkin Lymphoma
1 trial -
Loncastuximab Tesirine and Acalabrutinib
ADC Therapeutics SA
Chronic Lymphocytic Leukemia
1 trial -
Loncastuximab Tesirine and Durvalumab
ADC Therapeutics SA
Diffuse Large B-Cell Lymphoma
1 trial -
Loncastuximab tesirine and rituximab (Lonca-R)
ADC Therapeutics SA
Central Nervous System Lymphoma
1 trial
Frequently asked questions
How many clinical projects does ADC Therapeutics have?
14 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.